IRC
SRNE

Investors Research Corp’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Investors Research Corp’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-50
Closed -$44 – 1166
2022
Q4 		$44 Hold
50
– – ﹤0.01% 1129
2022
Q3 		$0 Hold
50
– – ﹤0.01% 1162
2022
Q2 		$0 Hold
50
– – ﹤0.01% 1185
2022
Q1 		$0 Hold
50
– – ﹤0.01% 1120
2021
Q4 		$0 Hold
50
– – ﹤0.01% 1073
2021
Q3 		$0 Hold
50
– – ﹤0.01% 1053
2021
Q2 		$0 Hold
50
– – ﹤0.01% 1035
2021
Q1 		$0 Hold
50
– – ﹤0.01% 1099
2020
Q4 		$0 Hold
50
– – ﹤0.01% 1121
2020
Q3 		$1K Buy
+50
New +$458 ﹤0.01% 1074

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.04B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Investors Research Corp's SRNE Position: Q1 2023 in Review

Investors Research Corp sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 50 shares — an estimated $44 sold.

Investors Research Corp first reported a position in SRNE in Q3 2020 and held it in 10 quarters. The position peaked at $1K in Q3 2020. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

  • Investors Research Corp reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Investors Research Corp sold 50 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $44.
  • Investors Research Corp first reported a position in Sorrento Therapeutics, Inc. in Q3 2020 and held it in 10 quarters.
  • Investors Research Corp's Sorrento Therapeutics, Inc. position peaked at $1K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Investors Research Corp's 13F filing for Q1 2023, filed 11 May 2023.